166 related articles for article (PubMed ID: 22901004)
21. Vitamin D receptor knockout mice exhibit elongated intestinal microvilli and increased ezrin expression.
Kühne H; Hause G; Grundmann SM; Schutkowski A; Brandsch C; Stangl GI
Nutr Res; 2016 Feb; 36(2):184-92. PubMed ID: 26606857
[TBL] [Abstract][Full Text] [Related]
22. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
23. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
24. Combining Chemical Permeation Enhancers for Synergistic Effects.
du Toit T; Malan MM; Lemmer HJ; Gouws C; Aucamp ME; Breytenbach WJ; Hamman JH
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):575-86. PubMed ID: 25939330
[TBL] [Abstract][Full Text] [Related]
25. Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells.
Lin YH; Chung CK; Chen CT; Liang HF; Chen SC; Sung HW
Biomacromolecules; 2005; 6(2):1104-12. PubMed ID: 15762683
[TBL] [Abstract][Full Text] [Related]
26. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa.
Grainger CI; Greenwell LL; Martin GP; Forbes B
Eur J Pharm Biopharm; 2009 Feb; 71(2):318-24. PubMed ID: 18845252
[TBL] [Abstract][Full Text] [Related]
27. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery.
Sajeesh S; Bouchemal K; Sharma CP; Vauthier C
Eur J Pharm Biopharm; 2010 Feb; 74(2):209-18. PubMed ID: 19737614
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of intestinal absorption of macromolecules by spermine in rats.
Sugita Y; Takao K; Toyama Y; Shirahata A
Amino Acids; 2007 Aug; 33(2):253-60. PubMed ID: 17653818
[TBL] [Abstract][Full Text] [Related]
29. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2).
Opanasopit P; Aumklad P; Kowapradit J; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Puttipipatkhachorn S
Pharm Dev Technol; 2007; 12(5):447-55. PubMed ID: 17963144
[TBL] [Abstract][Full Text] [Related]
30. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
[TBL] [Abstract][Full Text] [Related]
31. Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution.
Vllasaliu D; Exposito-Harris R; Heras A; Casettari L; Garnett M; Illum L; Stolnik S
Int J Pharm; 2010 Nov; 400(1-2):183-93. PubMed ID: 20727955
[TBL] [Abstract][Full Text] [Related]
32. Chitosan solutions and particles: evaluation of their permeation enhancing potential on MDCK cells used as blood brain barrier model.
Hombach J; Bernkop-Schnürch A
Int J Pharm; 2009 Jul; 376(1-2):104-9. PubMed ID: 19409469
[TBL] [Abstract][Full Text] [Related]
33. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
[TBL] [Abstract][Full Text] [Related]
34. A novel tool to characterize paracellular transport: the APTS-dextran ladder.
Neuhaus W; Bogner E; Wirth M; Trzeciak J; Lachmann B; Gabor F; Noe CR
Pharm Res; 2006 Jul; 23(7):1491-501. PubMed ID: 16779707
[TBL] [Abstract][Full Text] [Related]
35. Impact of Lipid-Based Drug Delivery Systems on the Transport and Uptake of Insulin Across Caco-2 Cell Monolayers.
Li P; Nielsen HM; Müllertz A
J Pharm Sci; 2016 Sep; 105(9):2743-2751. PubMed ID: 26921121
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
37. The role of glutathione in the permeation enhancing effect of thiolated polymers.
Clausen AE; Kast CE; Bernkop-Schnürch A
Pharm Res; 2002 May; 19(5):602-8. PubMed ID: 12069161
[TBL] [Abstract][Full Text] [Related]
38. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
39. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
40. Morphological and release characterization of nanoparticles formulated with poly (dl-lactide-co-glycolide) (PLGA) and lupeol: In vitro permeability and modulator effect on NF-κB in Caco-2 cell system stimulated with TNF-α.
Cháirez-Ramírez MH; Sánchez-Burgos JA; Gomes C; Moreno-Jiménez MR; González-Laredo RF; Bernad-Bernad MJ; Medina-Torres L; Ramírez-Mares MV; Gallegos-Infante JA; Rocha-Guzmán NE
Food Chem Toxicol; 2015 Nov; 85():2-9. PubMed ID: 26260749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
